ARTICLE | Company News
Corixa and QLTI collaborate
March 3, 2000 8:00 AM UTC
CRXA will provide QLT (QLTI; TSE:QLT) with exclusive rights to use its immunotherapeutic compounds, which QLTI intends to evaluate in combination with its photodynamic therapy. The collaboration will ...